» Articles » PMID: 33432169

Aneuploidy As a Promoter and Suppressor of Malignant Growth

Overview
Journal Nat Rev Cancer
Specialty Oncology
Date 2021 Jan 12
PMID 33432169
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Aneuploidy has been recognized as a hallmark of tumorigenesis for more than 100 years, but the connection between chromosomal errors and malignant growth has remained obscure. New evidence emerging from both basic and clinical research has illuminated a complicated relationship: despite its frequency in human tumours, aneuploidy is not a universal driver of cancer development and instead can exert substantial tumour-suppressive effects. The specific consequences of aneuploidy are highly context dependent and are influenced by a cell's genetic and environmental milieu. In this Review, we discuss the diverse facets of cancer biology that are shaped by aneuploidy, including metastasis, drug resistance and immune recognition, and we highlight aneuploidy's distinct roles as both a tumour promoter and an anticancer vulnerability.

Citing Articles

Deletion of Xist repeat B disrupts cell cycle and asymmetric cell division through Usp9x hyperactivation in mice.

Liang M, Zhang L, Gong H, Yang L, Wang H, Song N Nucleic Acids Res. 2025; 53(5).

PMID: 40042815 PMC: 11880805. DOI: 10.1093/nar/gkaf142.


A perspective review on the systematic implementation of ctDNA in phase I clinical trial drug development.

Guigal-Stephan N, Lockhart B, Moser T, Heitzer E J Exp Clin Cancer Res. 2025; 44(1):79.

PMID: 40022112 PMC: 11871688. DOI: 10.1186/s13046-025-03328-4.


RNA methyltransferase SPOUT1/CENP-32 links mitotic spindle organization with the neurodevelopmental disorder SpADMiSS.

Dharmadhikari A, Abad M, Khan S, Maroofian R, Sands T, Ullah F Nat Commun. 2025; 16(1):1703.

PMID: 39962046 PMC: 11833075. DOI: 10.1038/s41467-025-56876-w.


Proteogenomic analysis reveals adaptive strategies for alleviating the consequences of aneuploidy in cancer.

Bokenkamp J, Keuper K, Redel S, Barthel K, Johnson L, Becker A EMBO J. 2025; .

PMID: 39930267 DOI: 10.1038/s44318-025-00372-w.


Unravelling single-cell DNA replication timing dynamics using machine learning reveals heterogeneity in cancer progression.

Josephides J, Chen C Nat Commun. 2025; 16(1):1472.

PMID: 39922809 PMC: 11807193. DOI: 10.1038/s41467-025-56783-0.


References
1.
Biancotti J, Narwani K, Mandefro B, Golan-Lev T, Buehler N, Hill D . The in vitro survival of human monosomies and trisomies as embryonic stem cells. Stem Cell Res. 2012; 9(3):218-24. DOI: 10.1016/j.scr.2012.07.002. View

2.
van den Berg M, van Maarle M, van Wely M, Goddijn M . Genetics of early miscarriage. Biochim Biophys Acta. 2012; 1822(12):1951-9. DOI: 10.1016/j.bbadis.2012.07.001. View

3.
Weaver B, Cleveland D . Does aneuploidy cause cancer?. Curr Opin Cell Biol. 2006; 18(6):658-67. DOI: 10.1016/j.ceb.2006.10.002. View

4.
Donne R, Saroul-Ainama M, Cordier P, Celton-Morizur S, Desdouets C . Polyploidy in liver development, homeostasis and disease. Nat Rev Gastroenterol Hepatol. 2020; 17(7):391-405. DOI: 10.1038/s41575-020-0284-x. View

5.
Tanaka K, Goto H, Nishimura Y, Kasahara K, Mizoguchi A, Inagaki M . Tetraploidy in cancer and its possible link to aging. Cancer Sci. 2018; 109(9):2632-2640. PMC: 6125447. DOI: 10.1111/cas.13717. View